Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Synovial Fluid in Knee Osteoarthritis Extends Proinflammatory Niche for Macrophage Polarization.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI
    • Subject Terms:
      Osteoarthritis, Knee*/metabolism; Humans ; Synovial Fluid/metabolism ; U937 Cells ; Leukocytes, Mononuclear/metabolism ; Proteome/metabolism ; Cytokines/metabolism ; Macrophages/metabolism
    • Abstract:
      Macrophage polarization is a steering factor of osteoarthritis (OA) progression. Synovial fluid (SF) obtained from OA patients with different Kellgren-Lawrence grades (KL grades) holds several proinflammatory factors and was hypothesized to induce macrophage differentiation and polarization by providing the needed microenvironment. U937 cells and peripheral-blood-mononuclear-cell-derived monocytes (PBMC-derived CD14+ cells) were induced with SFs of progressive KL grades for 48 h, and the status of the differentiated cells was evaluated by cell surface markers representing M1 and M2 macrophage phenotypes. Functional viability assessment of the differentiated cells was performed by cytokine estimation. The fraction of macrophages and their phenotypes were estimated by immunophenotyping of SF-isolated cells of different KL grades. A grade-wise proteome analysis of SFs was performed in search of the factors which are influential in macrophage differentiation and polarization. In the assay on U937 cells, induction with SF of KL grade III and IV showed a significant increase in M1 type (CD86+). The percentage of M2 phenotype (CD163+) was significantly higher after the induction with SF of KL grade II. A Significantly higher M1/M2 ratio was estimated in the cells induced with KL grade III and IV. The cell differentiation pattern in the assay on PBMC-derived CD14+ cells showed a grade-wise decline in both M1 (CD11C+, CD86+) and M2 phenotype (CD163+). Cytokine estimation specific to M1 (TNF-α, IL-6, IL-1β, IFN-γ) and M2 (IL-4 and IL-10) macrophages corelated with the differentiation pattern in the U937 cell assay, while it did not reveal any significant changes in the PBMC-derived CD14+ cells assay. SF cells' immunophenotyping showed the highest percentage of CD14+ macrophages in KL grade II; CD86+ and CD163+ cells were minimal in all KL grades' SFs. The proteome analysis revealed significantly expressed MIF, CAPG/MCP, osteopontin, and RAS-related RAB proteins in KL grade III and IV samples, which are linked with macrophages' movement, polarization, and migration-behavior. In conclusion, this study demonstrated that SF in OA joints acts as a niche and facilitates M1 phenotype polarization by providing a proinflammatory microenvironment.
    • References:
      Clin Orthop Relat Res. 1992 Jan;(274):294-9. (PMID: 1729015)
      Mol Cell Proteomics. 2014 Nov;13(11):3138-51. (PMID: 25096996)
      Semin Arthritis Rheum. 2014 Apr;43(5):579-87. (PMID: 24262930)
      PLoS One. 2010 Jan 13;5(1):e8668. (PMID: 20084270)
      Scand J Clin Lab Invest. 2017 Nov;77(7):520-526. (PMID: 28737953)
      Osteoarthritis Cartilage. 2018 Sep;26(9):1247-1256. (PMID: 29753948)
      Osteoarthritis Cartilage. 2014 Aug;22(8):1167-75. (PMID: 24911520)
      Prog Biophys Mol Biol. 2019 Nov;148:4-11. (PMID: 31226307)
      Joint Bone Spine. 2013 Dec;80(6):568-73. (PMID: 24176735)
      Arthritis Res Ther. 2019 Jan 18;21(1):26. (PMID: 30658702)
      Oncol Lett. 2020 Nov;20(5):244. (PMID: 32973957)
      J Immunol. 2009 Mar 1;182(5):3084-94. (PMID: 19234205)
      Osteoarthritis Cartilage. 2016 Dec;24(12):2162-2170. (PMID: 27502245)
      Biochimie. 2019 Jan;156:79-91. (PMID: 30315853)
      Osteoarthritis Cartilage. 2016 Sep;24(9):1613-21. (PMID: 27084348)
      Curr Opin Rheumatol. 2008 Sep;20(5):565-72. (PMID: 18698179)
      Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):84-9. (PMID: 15730927)
      Immunity. 2016 Apr 19;44(4):755-68. (PMID: 26992565)
      Osteoporos Int. 2011 Jul;22(7):2175-86. (PMID: 21060993)
      Adv Clin Chem. 2021;100:37-90. (PMID: 33453867)
      Int J Biol Sci. 2018 Mar 10;14(4):398-405. (PMID: 29725261)
      Clin Transl Immunology. 2020 Dec 20;9(12):e1222. (PMID: 33363732)
      Exp Hematol. 1999 Feb;27(2):353-64. (PMID: 10029175)
      Eur Cytokine Netw. 2006 Mar;17(1):4-12. (PMID: 16613757)
      Nat Rev Immunol. 2017 Jul;17(7):451-460. (PMID: 28461703)
      J Cell Sci. 2003 Jun 15;116(Pt 12):2377-88. (PMID: 12766184)
      Exp Ther Med. 2018 Dec;16(6):5009-5014. (PMID: 30546406)
      Genes (Basel). 2021 Jun 29;12(7):. (PMID: 34209473)
      Nat Biotechnol. 2008 Dec;26(12):1367-72. (PMID: 19029910)
      Int Orthop. 2009 Jun;33(3):873-7. (PMID: 18350290)
      Free Radic Biol Med. 2021 May 1;167:81-93. (PMID: 33711419)
      BBA Clin. 2016 May 12;6:1-4. (PMID: 27331021)
      Genes Dis. 2020 Jun 27;9(1):128-139. (PMID: 35005113)
      J Leukoc Biol. 1996 Apr;59(4):555-61. (PMID: 8613704)
      Immunity. 2020 Mar 17;52(3):434-451. (PMID: 32187515)
      Biol Reprod. 2016 Feb;94(2):38. (PMID: 26764347)
      Arch Orthop Trauma Surg. 2019 Sep;139(9):1287-1292. (PMID: 31209613)
      Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94. (PMID: 23641259)
      Clin Immunol. 2013 Mar;146(3):185-96. (PMID: 23360836)
      Proteomics. 2021 Aug;21(15):e2100005. (PMID: 34051048)
      PLoS One. 2014 Feb 03;9(2):e87680. (PMID: 24498352)
      Immunity. 2013 Mar 21;38(3):570-80. (PMID: 23434060)
      Oncogene. 2017 Jun 29;36(26):3749-3759. (PMID: 28218903)
      Arthritis Rheumatol. 2017 Jun;69(6):1221-1232. (PMID: 28141918)
      J Immunol. 2005 Jul 1;175(1):342-9. (PMID: 15972667)
      Mol Cell Proteomics. 2014 Sep;13(9):2513-26. (PMID: 24942700)
      Cell Mol Life Sci. 2018 Aug;75(15):2873-2886. (PMID: 29441425)
      Stem Cells Int. 2019 Jan 15;2019:8169172. (PMID: 30766606)
      Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489. (PMID: 33237286)
      In Vitro Cell Dev Biol Anim. 2015 Sep;51(8):843-50. (PMID: 26138240)
      Indian J Pharmacol. 2018 Jan-Feb;50(1):22-29. (PMID: 29861524)
      Osteoarthritis Cartilage. 2020 May;28(5):639-645. (PMID: 32028022)
      J Immunol. 2007 Sep 1;179(5):3242-8. (PMID: 17709540)
      Front Immunol. 2014 Oct 17;5:514. (PMID: 25368618)
      J Proteomics. 2010 Jan 3;73(3):602-18. (PMID: 19683082)
    • Contributed Indexing:
      Keywords: Kellgren-Lawrence score; M1/M2 ratio; macrophages; niche; osteoarthritis; synovial fluid; synovitis
    • Accession Number:
      0 (Proteome)
      0 (Cytokines)
    • Publication Date:
      Date Created: 20221223 Date Completed: 20221226 Latest Revision: 20230115
    • Publication Date:
      20250114
    • Accession Number:
      PMC9776803
    • Accession Number:
      10.3390/cells11244115
    • Accession Number:
      36552878